Last reviewed · How we verify

NCT05318209

Effect of Closed-chain Shoulder Girdle Scapular Depression Exercise on Shoulder Impingement Syndrome

Status unknown NA Last updated 8 February 2024
What this trial tests

NA trial testing Exercise in Shoulder Impingement Syndrome in 46 participants. Status unknown.

Timeline
1 February 2024
Primary endpoint
1 March 2024
1 December 2024

Quick facts

Lead sponsorNasr Awad Abdelkader Othman
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposetreatment
Enrollment46
Start date1 February 2024
Primary completion1 March 2024
Estimated completion1 December 2024
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Nasr Awad Abdelkader Othman

Who can join

Adults 25 to 45, any sex, with Shoulder Impingement Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

forty patients will be assigned randomly into 2 equal groups Study group (n=23) will receive "closed-chain shoulder girdle scapular depression exercise" in addition to Stretching for posterior capsule \& pectoralis minor, Eccentric exercise for external rotators and Strength exercises for serrates anterior and low intensity ultrasound Control group B (n=23) will receive "shoulder girdle depression against manual resistance exercise" in addition to stretching for posterior capsule \& pectoralis minor, eccentric exercise for external rotators and Strength exercises for serrates anterior and low intensity ultrasound . The exercise program will consist of 3 sessions / week for 5 weeks

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Exercise

Trials testing the same drug.

Other recruiting trials for Shoulder Impingement Syndrome

Currently open trials in the same condition.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05318209.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing